Biotech

All Articles

Roivant unveils new 'vant' to progress Bayer hypertension med

.Matt Gline is back along with a brand new 'vant' company, after the Roivant Sciences CEO spent Baye...

Viridian eye health condition phase 3 smash hits, accelerating push to rival Amgen

.Viridian Therapeutics' period 3 thyroid eye disease (TED) professional trial has hit its primary an...

Bain introduces $3B fund forever science companies

.Along with a sturdy track record for recognizing diamonds in the rough, Bain Capital Daily Life Sci...

Genentech's cancer cells restructure brought in 'for medical causes'

.The recent decision to merge Genentech's pair of cancer cells divisions was actually created "scien...

Tern oral GLP-1 shows 5% weight management at 1 month at greatest dosage

.Terns Pharmaceuticals' decision to drop its own liver condition ambitions may yet settle, after the...

Merck, Daiichi regular early effectiveness in small tissue lung cancer cells with improved ADC information

.Merck &amp Co.'s long-running effort to land a strike on tiny cell bronchi cancer (SCLC) has actual...

Boehringer, Bayer development bronchi cancer medicines towards Astra struggle

.Some individuals along with non-small tissue lung cancer cells (NSCLC) possess anomalies in a gene ...

MBX tries for $136M IPO to take rival to Ascendis right into period 3

.MBX has actually elaborated plans to take in over $136 thousand coming from its IPO as the biotech ...

Relay bosom cancer records tee up clash with AstraZeneca's Truqap

.Relay Rehabs has beaten its survival objective in a first-in-human bust cancer study, installing th...

AZ details AI-enabled TROP2 biomarker strategy for Daiichi ADC

.AstraZeneca has made use of artificial intelligence to create an one-of-a-kind biomarker for its Da...